Why the study?
Is platelet activation and destruction increased in patients with rheumatic heart disease involving the mitral valve compared to normal controls?
Population
24 patients with rheumatic heart disease (RHD) involving the mitral valve, and normal controls
Design
Case-control
Authors
Loading...
Elevated platelet activation markers in RHD may signal higher thrombotic risk; leaves open whether antiplatelet therapy improves mitral valve outcomes.
Is platelet activation and destruction increased in patients with rheumatic heart disease involving the mitral valve compared to normal controls?
Patients with rheumatic heart disease involving the mitral valve exhibit increased platelet activation and destruction compared to normal controls.
Kunishima et al. (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: